APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sclerotherapy Injection Needle

Compare research editions
View pricing & licenses

Selected research

Industry Research

Sclerotherapy Injection Needle Industry Research Report 2026

4 July 2026136 pages

Choose your research edition.

Industry ResearchSclerotherapy Injection Needle Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Sclerotherapy Injection Needle Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Sclerotherapy Injection Needle Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sclerotherapy Injection Needle Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Sclerotherapy Injection Needle Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Sclerotherapy Injection Needle market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Sclerotherapy Injection Needle is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Sclerotherapy Injection Needle is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Sclerotherapy Injection Needle is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Sclerotherapy Injection Needle include Boston Scientific, ZKSK Medical, Upex-med, TeleMed Systems, STERIS, Shaili Endoscopy, Micro-tech, Mednova Medical Technology and Jiangsu Vedkang Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Sclerotherapy Injection Needle market in terms of revenue (US$ million) and, where applicable, sales volume (M units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Sclerotherapy Injection Needle Market by Company

Boston Scientific

ZKSK Medical

Upex-med

TeleMed Systems

STERIS

Shaili Endoscopy

Micro-tech

Mednova Medical Technology

Jiangsu Vedkang Medical

Endo-Therapeutics

Diagmed Healthcare

Cook Medical

Conmed Corporation

ConMed

Changzhou Jiuhong Medical

Blueneem

Sclerotherapy Injection Needle Segment by Type

21G Needle

23G Needle

24G Needle

25G Needle

Others

Sclerotherapy Injection Needle Segment by Application

Hospital

Clinic

Others

Sclerotherapy Injection Needle Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sclerotherapy Injection Needle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sclerotherapy Injection Needle and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sclerotherapy Injection Needle.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Sclerotherapy Injection Needle manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Sclerotherapy Injection Needle by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Sclerotherapy Injection Needle in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Sclerotherapy Injection Needle Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Sclerotherapy Injection Needle Sales (M units) of Manufacturers (2021-2026) Table 7. Global Sclerotherapy Injection Needle Sales Market Share by Manufacturers (2021-2026) Table 8. Global Sclerotherapy Injection Needle Revenue of Manufacturers (2021-2026) Table 9. Global Sclerotherapy Injection Needle Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Sclerotherapy Injection Needle Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Sclerotherapy Injection Needle Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Sclerotherapy Injection Needle, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Sclerotherapy Injection Needle, Product Type & Application Table 14. Global Sclerotherapy Injection Needle Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Sclerotherapy Injection Needle by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Boston Scientific Company Information Table 19. Boston Scientific Business Overview Table 20. Boston Scientific Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Boston Scientific Sclerotherapy Injection Needle Product Portfolio Table 22. Boston Scientific Recent Developments Table 23. ZKSK Medical Company Information Table 24. ZKSK Medical Business Overview Table 25. ZKSK Medical Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. ZKSK Medical Sclerotherapy Injection Needle Product Portfolio Table 27. ZKSK Medical Recent Developments Table 28. Upex-med Company Information Table 29. Upex-med Business Overview Table 30. Upex-med Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Upex-med Sclerotherapy Injection Needle Product Portfolio Table 32. Upex-med Recent Developments Table 33. TeleMed Systems Company Information Table 34. TeleMed Systems Business Overview Table 35. TeleMed Systems Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. TeleMed Systems Sclerotherapy Injection Needle Product Portfolio Table 37. TeleMed Systems Recent Developments Table 38. STERIS Company Information Table 39. STERIS Business Overview Table 40. STERIS Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. STERIS Sclerotherapy Injection Needle Product Portfolio Table 42. STERIS Recent Developments Table 43. Shaili Endoscopy Company Information Table 44. Shaili Endoscopy Business Overview Table 45. Shaili Endoscopy Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Shaili Endoscopy Sclerotherapy Injection Needle Product Portfolio Table 47. Shaili Endoscopy Recent Developments Table 48. Micro-tech Company Information Table 49. Micro-tech Business Overview Table 50. Micro-tech Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Micro-tech Sclerotherapy Injection Needle Product Portfolio Table 52. Micro-tech Recent Developments Table 53. Mednova Medical Technology Company Information Table 54. Mednova Medical Technology Business Overview Table 55. Mednova Medical Technology Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Mednova Medical Technology Sclerotherapy Injection Needle Product Portfolio Table 57. Mednova Medical Technology Recent Developments Table 58. Jiangsu Vedkang Medical Company Information Table 59. Jiangsu Vedkang Medical Business Overview Table 60. Jiangsu Vedkang Medical Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Jiangsu Vedkang Medical Sclerotherapy Injection Needle Product Portfolio Table 62. Jiangsu Vedkang Medical Recent Developments Table 63. Endo-Therapeutics Company Information Table 64. Endo-Therapeutics Business Overview Table 65. Endo-Therapeutics Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Endo-Therapeutics Sclerotherapy Injection Needle Product Portfolio Table 67. Endo-Therapeutics Recent Developments Table 68. Diagmed Healthcare Company Information Table 69. Diagmed Healthcare Business Overview Table 70. Diagmed Healthcare Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Diagmed Healthcare Sclerotherapy Injection Needle Product Portfolio Table 72. Diagmed Healthcare Recent Developments Table 73. Cook Medical Company Information Table 74. Cook Medical Business Overview Table 75. Cook Medical Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Cook Medical Sclerotherapy Injection Needle Product Portfolio Table 77. Cook Medical Recent Developments Table 78. Conmed Corporation Company Information Table 79. Conmed Corporation Business Overview Table 80. Conmed Corporation Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Conmed Corporation Sclerotherapy Injection Needle Product Portfolio Table 82. Conmed Corporation Recent Developments Table 83. ConMed Company Information Table 84. ConMed Business Overview Table 85. ConMed Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. ConMed Sclerotherapy Injection Needle Product Portfolio Table 87. ConMed Recent Developments Table 88. Changzhou Jiuhong Medical Company Information Table 89. Changzhou Jiuhong Medical Business Overview Table 90. Changzhou Jiuhong Medical Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Changzhou Jiuhong Medical Sclerotherapy Injection Needle Product Portfolio Table 92. Changzhou Jiuhong Medical Recent Developments Table 93. Blueneem Company Information Table 94. Blueneem Business Overview Table 95. Blueneem Sclerotherapy Injection Needle Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Blueneem Sclerotherapy Injection Needle Product Portfolio Table 97. Blueneem Recent Developments Table 98. Global Sclerotherapy Injection Needle Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Sclerotherapy Injection Needle Sales by Region (2021-2026) & (M units) Table 100. Global Sclerotherapy Injection Needle Sales Market Share by Region (2021-2026) Table 101. Global Sclerotherapy Injection Needle Sales by Region (2027-2032) & (M units) Table 102. Global Sclerotherapy Injection Needle Sales Market Share by Region (2027-2032) Table 103. Global Sclerotherapy Injection Needle Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Sclerotherapy Injection Needle Revenue Market Share by Region (2021-2026) Table 105. Global Sclerotherapy Injection Needle Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Sclerotherapy Injection Needle Revenue Market Share by Region (2027-2032) Table 107. North America Sclerotherapy Injection Needle Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Sclerotherapy Injection Needle Sales by Country (2021-2026) & (M units) Table 109. North America Sclerotherapy Injection Needle Sales by Country (2027-2032) & (M units) Table 110. North America Sclerotherapy Injection Needle Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Sclerotherapy Injection Needle Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Sclerotherapy Injection Needle Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Sclerotherapy Injection Needle Sales by Country (2021-2026) & (M units) Table 114. Europe Sclerotherapy Injection Needle Sales by Country (2027-2032) & (M units) Table 115. Europe Sclerotherapy Injection Needle Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Sclerotherapy Injection Needle Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Sclerotherapy Injection Needle Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Sclerotherapy Injection Needle Sales by Country (2021-2026) & (M units) Table 119. Asia Pacific Sclerotherapy Injection Needle Sales by Country (2027-2032) & (M units) Table 120. Asia Pacific Sclerotherapy Injection Needle Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Sclerotherapy Injection Needle Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Sclerotherapy Injection Needle Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Sclerotherapy Injection Needle Sales by Country (2021-2026) & (M units) Table 124. South America Sclerotherapy Injection Needle Sales by Country (2027-2032) & (M units) Table 125. South America Sclerotherapy Injection Needle Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Sclerotherapy Injection Needle Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Sclerotherapy Injection Needle Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Sclerotherapy Injection Needle Sales by Country (2021-2026) & (M units) Table 129. Middle East and Africa Sclerotherapy Injection Needle Sales by Country (2027-2032) & (M units) Table 130. Middle East and Africa Sclerotherapy Injection Needle Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Sclerotherapy Injection Needle Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Sclerotherapy Injection Needle Sales by Type (2021-2026) & (M units) Table 133. Global Sclerotherapy Injection Needle Sales by Type (2027-2032) & (M units) Table 134. Global Sclerotherapy Injection Needle Sales Market Share by Type (2021-2026) Table 135. Global Sclerotherapy Injection Needle Sales Market Share by Type (2027-2032) Table 136. Global Sclerotherapy Injection Needle Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Sclerotherapy Injection Needle Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Sclerotherapy Injection Needle Revenue Market Share by Type (2021-2026) Table 139. Global Sclerotherapy Injection Needle Revenue Market Share by Type (2027-2032) Table 140. Global Sclerotherapy Injection Needle Price by Type (2021-2026) & (USD/unit) Table 141. Global Sclerotherapy Injection Needle Price by Type (2027-2032) & (USD/unit) Table 142. Global Sclerotherapy Injection Needle Sales by Application (2021-2026) & (M units) Table 143. Global Sclerotherapy Injection Needle Sales by Application (2027-2032) & (M units) Table 144. Global Sclerotherapy Injection Needle Sales Market Share by Application (2021-2026) Table 145. Global Sclerotherapy Injection Needle Sales Market Share by Application (2027-2032) Table 146. Global Sclerotherapy Injection Needle Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Sclerotherapy Injection Needle Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Sclerotherapy Injection Needle Revenue Market Share by Application (2021-2026) Table 149. Global Sclerotherapy Injection Needle Revenue Market Share by Application (2027-2032) Table 150. Global Sclerotherapy Injection Needle Price by Application (2021-2026) & (USD/unit) Table 151. Global Sclerotherapy Injection Needle Price by Application (2027-2032) & (USD/unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Sclerotherapy Injection Needle Distributors List Table 155. Sclerotherapy Injection Needle Customers List Table 156. Sclerotherapy Injection Needle Industry Trends Table 157. Sclerotherapy Injection Needle Industry Drivers Table 158. Sclerotherapy Injection Needle Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Sclerotherapy Injection Needle Product Image Figure 5. Global Sclerotherapy Injection Needle Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Sclerotherapy Injection Needle Market Size (2021-2032) & (US$ Million) Figure 7. Global Sclerotherapy Injection Needle Sales (2021-2032) & (M units) Figure 8. Global Sclerotherapy Injection Needle Average Price (USD/unit) & (2021-2032) Figure 9. 21G Needle Product Image Figure 10. 23G Needle Product Image Figure 11. 24G Needle Product Image Figure 12. 25G Needle Product Image Figure 13. Others Product Image Figure 14. Hospital Product Image Figure 15. Clinic Product Image Figure 16. Others Product Image Figure 17. Global Sclerotherapy Injection Needle Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Sclerotherapy Injection Needle, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Sclerotherapy Injection Needle Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Sclerotherapy Injection Needle Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Sclerotherapy Injection Needle Sales by Region in 2025 Figure 23. Global Sclerotherapy Injection Needle Revenue by Region in 2025 Figure 24. North America Sclerotherapy Injection Needle Market Size by Country in 2025 Figure 25. North America Sclerotherapy Injection Needle Sales Market Share by Country (2021-2032) Figure 26. North America Sclerotherapy Injection Needle Revenue Market Share by Country (2021-2032) Figure 27. United States Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Sclerotherapy Injection Needle Market Size by Country in 2025 Figure 31. Europe Sclerotherapy Injection Needle Sales Market Share by Country (2021-2032) Figure 32. Europe Sclerotherapy Injection Needle Revenue Market Share by Country (2021-2032) Figure 33. Germany Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Sclerotherapy Injection Needle Market Size by Country in 2025 Figure 44. Asia Pacific Sclerotherapy Injection Needle Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Sclerotherapy Injection Needle Revenue Market Share by Country (2021-2032) Figure 46. China Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Sclerotherapy Injection Needle Market Size by Country in 2025 Figure 55. South America Sclerotherapy Injection Needle Sales Market Share by Country (2021-2032) Figure 56. South America Sclerotherapy Injection Needle Revenue Market Share by Country (2021-2032) Figure 57. Brazil Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Sclerotherapy Injection Needle Market Size by Country in 2025 Figure 61. Middle East and Africa Sclerotherapy Injection Needle Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Sclerotherapy Injection Needle Revenue Market Share by Country (2021-2032) Figure 63. Egypt Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Sclerotherapy Injection Needle Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Sclerotherapy Injection Needle Sales Market Share by Type (2021-2032) Figure 69. Global Sclerotherapy Injection Needle Revenue Market Share by Type (2021-2032) Figure 70. Global Sclerotherapy Injection Needle Price (USD/unit) by Type (2021-2032) Figure 71. Global Sclerotherapy Injection Needle Sales Market Share by Application (2021-2032) Figure 72. Global Sclerotherapy Injection Needle Revenue Market Share by Application (2021-2032) Figure 73. Global Sclerotherapy Injection Needle Price (USD/unit) by Application (2021-2032) Figure 74. Sclerotherapy Injection Needle Value Chain Figure 75. Sclerotherapy Injection Needle Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Sclerotherapy Injection Needle Industry Opportunities and Challenges

Scope & coverage.

Types
  • 21G Needle
  • 23G Needle
  • 24G Needle
  • 25G Needle
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Boston Scientific
  • ZKSK Medical
  • Upex-med
  • TeleMed Systems
  • STERIS
  • Shaili Endoscopy
  • Micro-tech
  • Mednova Medical Technology
  • Jiangsu Vedkang Medical
  • Endo-Therapeutics
  • Diagmed Healthcare
  • Cook Medical
  • Conmed Corporation
  • ConMed
  • Changzhou Jiuhong Medical
  • Blueneem

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Sclerotherapy Injection Needle Market Size (2021-2032)
  4. 2.2.2 Global Sclerotherapy Injection Needle Sales (2021-2032)
  5. 2.2.3 Global Sclerotherapy Injection Needle Market Average Price (2021-2032)
  6. 2.3 Sclerotherapy Injection Needle by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 21G Needle
  9. 2.3.3 23G Needle
  10. 2.3.4 24G Needle
  11. 2.3.5 25G Needle
  12. 2.3.6 Others
  13. 2.4 Sclerotherapy Injection Needle by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Hospital
  16. 2.4.3 Clinic
  17. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Sclerotherapy Injection Needle Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Sclerotherapy Injection Needle Sales (M units) of Manufacturers (2021-2026)
  3. 3.3 Global Sclerotherapy Injection Needle Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Sclerotherapy Injection Needle Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Sclerotherapy Injection Needle Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Sclerotherapy Injection Needle, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Sclerotherapy Injection Needle, Product Type & Application
  8. 3.8 Global Manufacturers of Sclerotherapy Injection Needle, Established Date
  9. 3.9 Global Sclerotherapy Injection Needle Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Boston Scientific
  2. 4.1.1 Boston Scientific Company Information
  3. 4.1.2 Boston Scientific Business Overview
  4. 4.1.3 Boston Scientific Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Boston Scientific Sclerotherapy Injection Needle Product Portfolio
  6. 4.1.5 Boston Scientific Recent Developments
  7. 4.2 ZKSK Medical
  8. 4.2.1 ZKSK Medical Company Information
  9. 4.2.2 ZKSK Medical Business Overview
  10. 4.2.3 ZKSK Medical Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 ZKSK Medical Sclerotherapy Injection Needle Product Portfolio
  12. 4.2.5 ZKSK Medical Recent Developments
  13. 4.3 Upex-med
  14. 4.3.1 Upex-med Company Information
  15. 4.3.2 Upex-med Business Overview
  16. 4.3.3 Upex-med Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Upex-med Sclerotherapy Injection Needle Product Portfolio
  18. 4.3.5 Upex-med Recent Developments
  19. 4.4 TeleMed Systems
  20. 4.4.1 TeleMed Systems Company Information
  21. 4.4.2 TeleMed Systems Business Overview
  22. 4.4.3 TeleMed Systems Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 TeleMed Systems Sclerotherapy Injection Needle Product Portfolio
  24. 4.4.5 TeleMed Systems Recent Developments
  25. 4.5 STERIS
  26. 4.5.1 STERIS Company Information
  27. 4.5.2 STERIS Business Overview
  28. 4.5.3 STERIS Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 STERIS Sclerotherapy Injection Needle Product Portfolio
  30. 4.5.5 STERIS Recent Developments
  31. 4.6 Shaili Endoscopy
  32. 4.6.1 Shaili Endoscopy Company Information
  33. 4.6.2 Shaili Endoscopy Business Overview
  34. 4.6.3 Shaili Endoscopy Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Shaili Endoscopy Sclerotherapy Injection Needle Product Portfolio
  36. 4.6.5 Shaili Endoscopy Recent Developments
  37. 4.7 Micro-tech
  38. 4.7.1 Micro-tech Company Information
  39. 4.7.2 Micro-tech Business Overview
  40. 4.7.3 Micro-tech Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Micro-tech Sclerotherapy Injection Needle Product Portfolio
  42. 4.7.5 Micro-tech Recent Developments
  43. 4.8 Mednova Medical Technology
  44. 4.8.1 Mednova Medical Technology Company Information
  45. 4.8.2 Mednova Medical Technology Business Overview
  46. 4.8.3 Mednova Medical Technology Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Mednova Medical Technology Sclerotherapy Injection Needle Product Portfolio
  48. 4.8.5 Mednova Medical Technology Recent Developments
  49. 4.9 Jiangsu Vedkang Medical
  50. 4.9.1 Jiangsu Vedkang Medical Company Information
  51. 4.9.2 Jiangsu Vedkang Medical Business Overview
  52. 4.9.3 Jiangsu Vedkang Medical Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Jiangsu Vedkang Medical Sclerotherapy Injection Needle Product Portfolio
  54. 4.9.5 Jiangsu Vedkang Medical Recent Developments
  55. 4.10 Endo-Therapeutics
  56. 4.10.1 Endo-Therapeutics Company Information
  57. 4.10.2 Endo-Therapeutics Business Overview
  58. 4.10.3 Endo-Therapeutics Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Endo-Therapeutics Sclerotherapy Injection Needle Product Portfolio
  60. 4.10.5 Endo-Therapeutics Recent Developments
  61. 4.11 Diagmed Healthcare
  62. 4.11.1 Diagmed Healthcare Company Information
  63. 4.11.2 Diagmed Healthcare Business Overview
  64. 4.11.3 Diagmed Healthcare Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Diagmed Healthcare Sclerotherapy Injection Needle Product Portfolio
  66. 4.11.5 Diagmed Healthcare Recent Developments
  67. 4.12 Cook Medical
  68. 4.12.1 Cook Medical Company Information
  69. 4.12.2 Cook Medical Business Overview
  70. 4.12.3 Cook Medical Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Cook Medical Sclerotherapy Injection Needle Product Portfolio
  72. 4.12.5 Cook Medical Recent Developments
  73. 4.13 Conmed Corporation
  74. 4.13.1 Conmed Corporation Company Information
  75. 4.13.2 Conmed Corporation Business Overview
  76. 4.13.3 Conmed Corporation Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Conmed Corporation Sclerotherapy Injection Needle Product Portfolio
  78. 4.13.5 Conmed Corporation Recent Developments
  79. 4.14 ConMed
  80. 4.14.1 ConMed Company Information
  81. 4.14.2 ConMed Business Overview
  82. 4.14.3 ConMed Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 ConMed Sclerotherapy Injection Needle Product Portfolio
  84. 4.14.5 ConMed Recent Developments
  85. 4.15 Changzhou Jiuhong Medical
  86. 4.15.1 Changzhou Jiuhong Medical Company Information
  87. 4.15.2 Changzhou Jiuhong Medical Business Overview
  88. 4.15.3 Changzhou Jiuhong Medical Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Changzhou Jiuhong Medical Sclerotherapy Injection Needle Product Portfolio
  90. 4.15.5 Changzhou Jiuhong Medical Recent Developments
  91. 4.16 Blueneem
  92. 4.16.1 Blueneem Company Information
  93. 4.16.2 Blueneem Business Overview
  94. 4.16.3 Blueneem Sclerotherapy Injection Needle Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Blueneem Sclerotherapy Injection Needle Product Portfolio
  96. 4.16.5 Blueneem Recent Developments
5 Global Sclerotherapy Injection Needle Market Scenario by Region
  1. 5.1 Global Sclerotherapy Injection Needle Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Sclerotherapy Injection Needle Sales by Region: 2021-2032
  3. 5.2.1 Global Sclerotherapy Injection Needle Sales by Region: 2021-2026
  4. 5.2.2 Global Sclerotherapy Injection Needle Sales by Region: 2027-2032
  5. 5.3 Global Sclerotherapy Injection Needle Revenue by Region: 2021-2032
  6. 5.3.1 Global Sclerotherapy Injection Needle Revenue by Region: 2021-2026
  7. 5.3.2 Global Sclerotherapy Injection Needle Revenue by Region: 2027-2032
  8. 5.4 North America Sclerotherapy Injection Needle Market Facts & Figures by Country
  9. 5.4.1 North America Sclerotherapy Injection Needle Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Sclerotherapy Injection Needle Sales by Country (2021-2032)
  11. 5.4.3 North America Sclerotherapy Injection Needle Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Sclerotherapy Injection Needle Market Facts & Figures by Country
  16. 5.5.1 Europe Sclerotherapy Injection Needle Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Sclerotherapy Injection Needle Sales by Country (2021-2032)
  18. 5.5.3 Europe Sclerotherapy Injection Needle Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Sclerotherapy Injection Needle Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Sclerotherapy Injection Needle Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Sclerotherapy Injection Needle Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Sclerotherapy Injection Needle Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Sclerotherapy Injection Needle Market Facts & Figures by Country
  41. 5.7.1 South America Sclerotherapy Injection Needle Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Sclerotherapy Injection Needle Sales by Country (2021-2032)
  43. 5.7.3 South America Sclerotherapy Injection Needle Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Sclerotherapy Injection Needle Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Sclerotherapy Injection Needle Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Sclerotherapy Injection Needle Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Sclerotherapy Injection Needle Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Sclerotherapy Injection Needle Sales by Type (2021-2032)
  2. 6.1.1 Global Sclerotherapy Injection Needle Sales by Type (2021-2032) & (M units)
  3. 6.1.2 Global Sclerotherapy Injection Needle Sales Market Share by Type (2021-2032)
  4. 6.2 Global Sclerotherapy Injection Needle Revenue by Type (2021-2032)
  5. 6.2.1 Global Sclerotherapy Injection Needle Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Sclerotherapy Injection Needle Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Sclerotherapy Injection Needle Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Sclerotherapy Injection Needle Sales by Application (2021-2032)
  2. 7.1.1 Global Sclerotherapy Injection Needle Sales by Application (2021-2032) & (M units)
  3. 7.1.2 Global Sclerotherapy Injection Needle Sales Market Share by Application (2021-2032)
  4. 7.2 Global Sclerotherapy Injection Needle Revenue by Application (2021-2032)
  5. 7.2.1 Global Sclerotherapy Injection Needle Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Sclerotherapy Injection Needle Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Sclerotherapy Injection Needle Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Sclerotherapy Injection Needle Value Chain Analysis
  2. 8.1.1 Sclerotherapy Injection Needle Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Sclerotherapy Injection Needle Production Mode & Process
  5. 8.2 Sclerotherapy Injection Needle Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Sclerotherapy Injection Needle Distributors
  8. 8.2.3 Sclerotherapy Injection Needle Customers
9 Global Sclerotherapy Injection Needle Analyzing Market Dynamics
  1. 9.1 Sclerotherapy Injection Needle Industry Trends
  2. 9.2 Sclerotherapy Injection Needle Industry Drivers
  3. 9.3 Sclerotherapy Injection Needle Industry Opportunities and Challenges
  4. 9.4 Sclerotherapy Injection Needle Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst